HUM

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.61%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.76%. June E-mini S&P futures (ESM26 ) rose +0.61%, and June E-mini Nasdaq futures...

The S&P 500 Index ($SPX ) (SPY ) today is up +0.81%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.74%. June E-mini S&P futures (ESM26 ) are up +0.77%, and June E-mini Nasdaq futures...

Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for “Artisan Value Fund”. A copy of the letter is available to download here. The Funds’ Investor Class: ARTLX, Advisor Class: APDLX, and Institutional Class: APHLX returned -3.54%, -3.50%. and 3.50%, respectively, in Q1 vs, 2.10% return for the Russell 1000® Value Index. Performance […]

Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for “Artisan Value Fund”. A copy of the letter is available to download here. The Funds’ Investor Class: ARTLX, Advisor Class: APDLX, and Institutional Class: APHLX returned -3.54%, -3.50%. and 3.50%, respectively, in Q1 vs, 2.10% return for the Russell 1000® Value Index. Performance […]

According to Kiplinger, the Congressional Joint Economic Committee found Medicare Advantage is overpaying insurers by $212 per enrollee. The figure looks small until you scale it. The data, scaled Multiply $212 against roughly 33 million Medicare Advantage enrollees and the system is leaking about $7 billion a year in excess payments to private insurers. Medicare ... Congressional Joint Economic Committee Pegs Medicare Advantage Overpayments at $7 Billion Annually and Rising

According to Kiplinger, the Congressional Joint Economic Committee found Medicare Advantage is overpaying insurers by $212 per enrollee. The figure looks small until you scale it. The data, scaled Multiply $212 against roughly 33 million Medicare Advantage enrollees and the system is leaking about $7 billion a year in excess payments to private insurers. Medicare ... Congressional Joint Economic Committee Pegs Medicare Advantage Overpayments at $7 Billion Annually and Rising

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.

Humana (HUM) is in focus after CVRx announced that the insurer has issued a Medicare Advantage coverage policy for Barostim therapy, including patients in the expanded BENEFIT-HF heart failure trial. See our latest analysis for Humana. The Barostim coverage decision comes as Humana’s latest share price of US$304.10 sits after a sharp 30 day share price return of 44.58% and a 90 day share price return of 59.63%, while the 1 year total shareholder return of 25.69% contrasts with weaker 3 and 5...

Humana (HUM) is in focus after CVRx announced that the insurer has issued a Medicare Advantage coverage policy for Barostim therapy, including patients in the expanded BENEFIT-HF heart failure trial. See our latest analysis for Humana. The Barostim coverage decision comes as Humana’s latest share price of US$304.10 sits after a sharp 30 day share price return of 44.58% and a 90 day share price return of 59.63%, while the 1 year total shareholder return of 25.69% contrasts with weaker 3 and 5...

Eagle Capital Management, an investment management company, released its first quarter 2026 investor letter. A copy of the letter is available to download here. The letter notes that individual stocks and subsectors are now more reactive to sentiments, reducing market efficiency but creating opportunities to add value. Over the last decade, multi-asset managers, or pods, […]

Eagle Capital Management, an investment management company, released its first quarter 2026 investor letter. A copy of the letter is available to download here. The letter notes that individual stocks and subsectors are now more reactive to sentiments, reducing market efficiency but creating opportunities to add value. Over the last decade, multi-asset managers, or pods, […]

Agilon Health Inc. (NYSE:AGL) is one of the best performing NYSE stocks so far in 2026. On April 27, Agilon Health announced the appointment of Tim O’Rourke as Chief Executive Officer and a member of the Board of Directors, effective May 7. He succeeds Ronald A. Williams, who has served as Executive Chairman since August 2025 […]

Agilon Health Inc. (NYSE:AGL) is one of the best performing NYSE stocks so far in 2026. On April 27, Agilon Health announced the appointment of Tim O’Rourke as Chief Executive Officer and a member of the Board of Directors, effective May 7. He succeeds Ronald A. Williams, who has served as Executive Chairman since August 2025 […]

Deutsche Bank just delivered one of the most aggressive analyst upgrades of 2026 on Humana (NYSE:HUM), lifting the managed care giant to Buy from Hold while nearly doubling its price target to $441 from $235. The move signals that one of Wall Street’s more cautious voices now sees a fundamental reset in the Humana franchise. ... Humana Just Got a Massive Upgrade From Deutsche Bank: Price Target Nearly Doubles to $441

Deutsche Bank just delivered one of the most aggressive analyst upgrades of 2026 on Humana (NYSE:HUM), lifting the managed care giant to Buy from Hold while nearly doubling its price target to $441 from $235. The move signals that one of Wall Street’s more cautious voices now sees a fundamental reset in the Humana franchise. ... Humana Just Got a Massive Upgrade From Deutsche Bank: Price Target Nearly Doubles to $441

Cigna downgraded, Humana upgraded: Wall Street's top analyst calls

Investing.com -- Analysts at Deutsche Bank turned more bullish on the managed care sector, upgrading shares of Humana, Centene, and Elevance Health to “Buy,” while downgrading The Cigna Group to “Hold” on valuation concerns.